MedPath

Comparing Pain Relief Strategies for Open Inguinal Hernioplasty Ultrasound-Guided Ilioinguinal Nerve Block vs. Lignocaine 5 percent Patch

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/04/083868
Lead Sponsor
King George Medical University Department of Anesthesiology
Brief Summary

Inguinal hernioplasty is one of the common elective surgeries performed. It is associated with mild to moderate pain. Ilioinguinal block minimizes pain after tissue injury, avoid spinal sensitization, and diminish the prevalence of chronic pain. The use of ultrasound technique in nerve block will allow real-time visualization of the nerves and drug distribution, so less drug will be needed and less side effects.



The lidocaine (5%) patch offers a double mode of action in the treatment of localized neuropathic pain, delivering a mechanical barrier effect as well as pharmaceutical action through voltage-gated sodium-channel block by lidocaine activity,



By conducting this study we want to compare analgesic effect of ilioinguinal nerve block and lignocaine 5% patch in patient undergoing inguinal hernioplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria
  • all patients are scheduled for open hernioplasty surgery ASA I.
  • III written form consent will be taken body weight 50-80 kg.
Exclusion Criteria

pregnancy or breastfeeding known allergy to components of the anesthesia drugs history of coagulopathy or bleeding disorders severe neurological or psychiatric disorders pre existing peripheral neuropathy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
post operative VAS score48 hours after surgery
Secondary Outcome Measures
NameTimeMethod
patient satisfaction for pain management48 hours post surgery

Trial Locations

Locations (1)

Department of Anaesthesiology

🇮🇳

Lucknow, UTTAR PRADESH, India

Department of Anaesthesiology
🇮🇳Lucknow, UTTAR PRADESH, India
DRSHREYANSHI TEOTIA
Principal investigator
08218063326
drshreyanshiteotia@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.